Search by Drug Name
A B C D E F G H I J K L M N O P Q R S T U V W X Y ZClinical Trials for LUPRON DEPOT-PED KIT
- Study to Test the Drug Darolutamide Along With the Drugs Leuprolide Acetate and Exemestane in Patients With Recurrent Ovarian Granulosa Cell Tumors
- Difluoromethylornithine and High Dose Testosterone With Enzalutamide in Metastatic Castration-Resistant Prostate Cancer
- Testing the Anti-Cancer Drug Darolutamide in Patients With Testosterone-driven Salivary Gland Cancers
- RElugolix VErsus LeUprolide Cardiac Trial
- Study to Evaluate the Pharmacodynamics and Efficacy of Leuprolide Tablets (Ovarest®) in Women With Endometriosis
- Pre-Exposure Prophylaxis (PrEP)- Gender Affirming Hormone Therapy (GAHT) Interactions in TGW
- Talazoparib With Androgen Deprivation Therapy and Abiraterone for the Treatment of Castration Sensitive Prostate Cancer
- Androgen Deprivation Therapy and Apalutamide With or Without Radiation Therapy for the Treatment of Biochemically Recurrent Prostate Cancer, RESTART Study
- Testing the Addition of Darolutamide to Hormonal Therapy (Androgen Deprivation Therapy [ADT]) After Surgery for Men With High-Risk Prostate Cancer, The ERADICATE Study
- Comparison Elagolix vs Depot Leuprolide Prior to Frozen Embryo Transfers in Patients With Endometriosis
- Treating Prostate Cancer That Has Come Back After Surgery With Apalutamide and Targeted Radiation Using PET/CT Imaging
- Sequential Testosterone and Enzalutamide Prevents Unfavorable Progression
- Bariatric Arterial Embolization for Men Starting Hormones for Prostate Cancer
- Study of Abiraterone Acetate, Atezolizumab, GnRH Analog and Radiation Therapy in Men With Newly Diagnosed Hormone-sensitive Prostate Cancer
- Reduced Intensity BMT for Immune Dysregulatory and Bone Marrow Failure Syndromes Using Post-Transplant Cyclophosphamide
- Neurobiology of Bulimia Nervosa
- Nivolumab + Docetaxel + ADT in mHSPC Patients With DDRD or Inflamed Tumors
- Characterizing the Neural Substrates of Irritability in Women: an Experimental Neuroendocrine Model
- Pilot Study of the IL-1 Antagonist Anakinra for the Treatment of Endometriosis Related Symptoms
- REGN2810 Followed by Chemoimmunotherapy for Newly Metastatic Hormone-sensitive Prostate Cancer
- Antiandrogen Therapy and SBRT in Treating Patients With Recurrent, Metastatic Prostate Cancer
- Examining Effects of Intrarosa in Women With Genitourinary Syndrome of Menopause/Vulvovaginal Atrophy
- Standard Systemic Therapy With or Without Definitive Treatment in Treating Participants With Metastatic Prostate Cancer
- A Pilot Study of 5-AZA and ATRA for Prostate Cancer With PSA-only Recurrence After Local Treatment
- COMbination of Bipolar Androgen Therapy and Nivolumab
- GnRH Agonist at Embryo Transfer: IVF Outcomes
- Phase II High Risk Prostate Cancer Trial Using Gene & Androgen Deprivation Therapies, Radiotherapy, & Surgery
- Radium Ra 223 Dichloride, Hormone Therapy and Stereotactic Body Radiation Therapy in Treating Patients With Metastatic Prostate Cancer
- AMH and Dosing Regimens for Initial IVF Stimulation Protocols
- A Study of Docetaxel + ARN-509 in Castration-Resistant Prostate Cancer
- Antiandrogen Therapy and Radiation Therapy With or Without Docetaxel in Treating Patients With Prostate Cancer That Has Been Removed by Surgery
- Menopausal Sleep Fragmentation and Body Fat Gain
- Regulation of Cervical Mucus Secretion
- Brown Adipose Tissue Activity in Pre- and Postmenopausal Women
- Neoadjuvant And Adjuvant Abiraterone Acetate + Apalutamide Prostate Cancer Undergoing Prostatectomy
- A Study of Pharmacokinetic/Pharmacodynamic Profile of Orally Administered Leuprolide in Healthy Female Volunteers
- Apalutamide and Leuprolide in Intermediate and High-risk Prostate Cancer
- Comparison of Trelstar Versus Lupron or Zoladex in Advanced Prostate Cancer
- NEOADjuvant Aromatase Inhibitor and Pertuzumab/Trastuzumab for Women With Breast Cancer
- Management of Castration-Resistant Prostate Cancer With Oligometastases
- Palbociclib in Combination With Tamoxifen as First Line Therapy for Metastatic Hormone Receptor Positive Breast Cancer
- A Trial Comparing Cardiovascular Safety of Degarelix Versus Leuprolide in Patients With Advanced Prostate Cancer and Cardiovascular Disease
- Effect of Increased Circulating Androgens on Granulosa Cell Responses to FSH.
- Micro RNAs to Predict Response to Androgen Deprivation Therapy
- Safety and Efficacy Study of Enzalutamide Plus Leuprolide in Patients With Nonmetastatic Prostate Cancer (EMBARK)
- Testosterone Revival Abolishes Negative Symptoms, Fosters Objective Response and Modulates Enzalutamide Resistance
- Enzalutamide Versus Standard Androgen Deprivation Therapy for the Treatment Hormone Sensitive Prostate Cancer
- Supportive Therapy in Androgen Deprivation Clinic in Improving Health Outcomes and Managing Side Effects in Patients With Prostate Cancer
- Levonorgestrel-releasing Intrauterine System in Patients With Endometriosis
- Ovarian Morphology and Theca Cell Androgen Production in Women With Polycystic Ovary Syndrome (PCOS)
- Vascular Mechanisms for the Effects of Loss of Ovarian Hormone Function on Cognition in Women
- Phase II Study of DCVAC/PCa Added to Hormone Therapy for Men With Metastatic Prostate Cancer
- RE-sensitizing With Supraphysiologic Testosterone to Overcome REsistance (The RESTORE Study)
- Efficacy of Recombinant FSH/GnRH Antagonist Protocol With and Without LH Adjunct for Egg Bank Donation
- Enzalutamide and Hormone Therapy Before, During, and After Radiation for High Risk Localized Prostate Cancer
- LHRH Analogue Therapy With Enzalutamide or Bicalutamide in Treating Patients With Metastatic Hormone Sensitive Prostate Cancer
- Natural Cycle In Vitro Fertilization
- Effects of Estrogen Deficiency on Energy Expenditure
- Reduced Intensity Haploidentical BMT for High Risk Solid Tumors
- Finite Androgen Ablation With or Without Abiraterone Acetate and Prednisone in Treating Patients With Recurrent Prostate Cancer
- Neurophysiology of Postpartum Depression in an Experimental Model of Pregnancy and Parturition
- Palifermin With Leuprolide Acetate for the Promotion of Immune Recovery Following Total Body Irradiation Based T-Cell Depleted Allogeneic Hematopoietic Stem Cell Transplantation
- Study to Evaluate Efficacy and Safety of Histrelin Subdermal Implant in Men With Advanced Prostate Cancer
- S1207 Hormone Therapy With or Without Everolimus in Treating Patients With Breast Cancer
- Effect of GnRH Antagonist vs Agonist Long on IVF Outcome, Peak Estradiol Level,and Duration of Stimulation
- Gene Expression Profile After Gonadotropin Releasing Hormone (GnRH) Agonist Trigger of Oocyte Maturation
- Study on Influence of Leutinizing Hormone (LH) on Oocyte Maturity
- A Novel Approach to Endometrial Preparation in Recipients of Donor Eggs
- Ipilimumab + Androgen Depravation Therapy in Prostate Cancer
- Pilot Study of Leuprolide to Improve Immune Function After Allogeneic Bone Marrow Transplantation
- Docetaxel Followed by Radical Prostatectomy in Patients With High Risk Localized Prostate Cancer
- Neoadjuvant Ipilimumab in Prostate Cancer
- Leuprolide Acetate or Goserelin Acetate With or Without Vismodegib Followed by Surgery in Treating Patients With Locally Advanced Prostate Cancer
- Influence of Male Hormones on Regional Fat Metabolism
- Theca Cell Function in Adolescents With Polycystic Ovary Syndrome (PCOS)
- Bicalutamide and Goserelin or Leuprolide Acetate With or Without Cixutumumab in Treating Patients With Newly Diagnosed Metastatic Prostate Cancer
- Impact of Hot Flashes on Sleep and Mood Disturbance
- A Pilot Study of Parenteral Testosterone and Oral Etoposide as Therapy for Men With Castration Resistant Prostate Cancer
- Pharmacodynamics of Lorelin Depot (Leuprorelin Acetate - Bergamo) Compared to Lupron Depot ® (Leuprorelin Acetate - Abbot)
- Abiraterone Prednisone and Hormonal Therapy Before and During Radiation Therapy in Localized Prostate Cancer
- Pazopanib as Second Line Therapy in Patients With Metastatic Prostate Cancer Refractory to Total Androgen Blockade
- Leuprolide Acetate or Goserelin Acetate Compared With Observation in Treating Patients With High-Risk Prostate Cancer Who Have Undergone Radical Prostatectomy
- A Study of Degarelix in Patients With Prostate Cancer
- Extended Endocrine Therapy for Premenopausal Women With Breast Cancer
- Oral Microdose Lupron Versus Luteal Estradiol Trial in Poor Responder In Vitro Fertilization (IVF) Patients
- Menopur® Versus Follistim® in Polycystic Ovarian Syndrome (PCOS)
- Follicle-Stimulating Hormone (FSH) and the Onset of Puberty
- Prevention of Obesity in Women Via Estradiol Regulation
- Postoperative Radiation Therapy, Hormonal Therapy and Concurrent Docetaxel for High Risk Pathologic Prostate Cancer
- Safety Extension Study Of Leuprolide Acetate (Lupron Depot) In The Treatment Of Central Precocious Puberty
- Study of Lupron Depot In The Treatment of Central Precocious Puberty
- Docetaxel, Bevacizumab and Androgen Deprivation Therapy After Definitive Local Therapy for Prostate Cancer
- A Study of Leuprolide 11.25 mg and 30 mg Administered Every 3 Months to Treat Central Precocious Puberty
- Sunitinib Malate, Hormone Ablation and Radiation Therapy in Patients With Prostate Cancer
- A Study of Leuprolide to Treat Prostate Cancer
- Androgen Deprivation Therapy and Vorinostat Followed by Radical Prostatectomy in Treating Patients With Localized Prostate Cancer
- Rapid Hormonal Cycling as Treatment for Patients With Prostate Cancer: The Men's Cycle
- Zometa on Bone Mineral Density in Prostate Cancer Patients Undergoing Androgen Ablation Therapy
- Hormone Therapy and Intensity-Modulated Radiation Therapy in Treating Patients With Metastatic Prostate Cancer
- Carboplatin Plus Docetaxel (Taxotere) in Anaplastic Prostate Cancer
- Hormone Therapy and Temsirolimus in Treating Patients With Relapsed Prostate Cancer
- Effect of Cetrorelex Acetate on Ovarian Function in Women Undergoing Chemotherapy
- Hormonal Ablation, Imatinib Mesylate and Docetaxel for Patients With Prostate Cancer
- GnRH Antagonist to Prepare Recipients for Embryo Transfer
- Treatment of Endometriosis With Norethindrone Acetate ( NA) VS. Gonadotropin- Releasing Hormone (GnRH) Agonist (Lupron Depot 11.25 mg)
- Understanding Experimentally Induced Hot Flushes
- Pazopanib Hydrochloride After Leuprolide Acetate or Goserelin Acetate in Treating Patients With Relapsed Prostate Cancer
- A Long-term Extension Study Evaluating a One-Month Dosing Regimen of Degarelix in Prostate Cancer Requiring Androgen Ablation Therapy
- External Beam Radiation Therapy (EBRT) With or Without Hormonal Therapy in Prostate Cancer
- Sunitinib Malate With Hormonal Ablation for Patients Who Will Have Prostatectomy
- The Efficacy and Safety of Degarelix One Month Dosing Regimens in Prostate Cancer
- Exisulind and Intermittent Androgen Suppression (ADT) in Biochemical Relapsed Prostate Cancer
- A Study to Evaluate the Ability of Lupron Depot to Enhance Immune Function Following Bone Marrow Transplantation
- Melanoma Vaccine With Peptides and Leuprolide
- Implant and External Radiation for Prostate Cancer With or Without Hormonal Therapy: A Prospective Randomized Trial
- Cancer and Osteoporosis Research With Alendronate and Lupron (C.O.R.A.L )
- Docetaxel, Androgen Ablation, and External-Beam Radiation Therapy in Patients With High-Risk Localized Prostate Cancer
- Effects of IAS in Men With Localized Biochemical Relapsed Prostate Cancer
- Lupron Sex Offender Therapy
- A Six-Month, Open-Label, Crossover Study Of the Maintenance Of Serum Testosterone And PSA Suppression After Switching Between Lupron 22.5 Mg And Eligard 22.5 Mg Or Zoladex 10.8 Mg And Eligard 22.5 Mg In Patients With Advanced Prostate Cancer
- Growth Hormone and GnRH Agonist in Adolescents With Acquired Hypothyroidism
- Polycystic Ovary Syndrome (PCOS) and Sleep Apnea
- Study of Bortezomib and Docetaxel for Patients With Hormone Refractory Prostate Cancer
- Hormone Therapy and Ipilimumab in Treating Patients With Advanced Prostate Cancer
- Oral Androgens in Man-3 (ORAL T-3) Pharmacokinetics of Oral Testosterone
- Insulin Resistance and Testosterone in Women
- Study of External Beam Radiation Therapy With and Without Hormonal Therapy to Treat Prostate Cancer
- Docetaxel, Radiation Therapy, and Hormone Therapy in Treating Patients With Locally Advanced Prostate Cancer
- Hormone Therapy and Radiation Therapy in Treating Patients With Prostate Cancer
- Radiation Therapy With or Without Antiandrogen Therapy in Treating Patients With Stage I or Stage II Prostate Cancer
- The Role of Hormones in Postpartum Mood Disorders
- The Effects of Reproductive Hormones on Mood and Behavior
- A Treatment Study for Premenstrual Syndrome (PMS)
- Testolactone for the Treatment of Girls With LHRH Resistant Precocious Puberty
Clinical trials list
click for details